Pandemic profiteering: Pfizer to earn a whooping $54 billion by year’s end, thanks to COVID-19
Global health authorities collaboratively approved Big Pharma vaccines and other treatments – despite adverse events and insufficient trials – to “cure” the Wuhan coronavirus (COVID-19). Nearly two years after the initial vaccine rollout, the number of cases are still big and the balance of Big …
Read More